Pricing Log in Create free account

Can-Fite Biopharma Ltd (CANF) vs Skye Bioscience, Inc. (SKYE)

Can-Fite Biopharma Ltd and Skye Bioscience, Inc. are both Biotechnology companies. Can-Fite Biopharma Ltd and Skye Bioscience, Inc. are of similar size ($4.9M and $4.6M). Skye Bioscience, Inc. has the higher net margin (0.00% vs −1,148.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Can-Fite Biopharma Ltd leads on 7 and Skye Bioscience, Inc. on 4.

Valuation

Metric CANF SKYE Biotechnology median
P/E n/m n/m 10.60
P/S 0.41 16.46 9.40
P/B 0.07 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.58 n/m 0.66
EV/Sales (8.67) 3.61 9.02
Earnings yield (802.80%) (1,026.26%) (32.88%)
Free cash flow yield (6,017.34%) (779.11%) (23.13%)

Profitability

Metric CANF SKYE Biotechnology median
Gross margin 0.00% 68.04% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,148.62%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (233.87%) (51.96%)
Return on assets 0.00% (159.80%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CANF SKYE Biotechnology median
Revenue growth (TTM) (3.36%) — 6.76%
EPS growth (last fiscal year) 45.23% (93.15%) 29.88%
Revenue growth, 5-year CAGR (11.90%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CANF SKYE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.60 0.95 4.97
Net debt to EBITDA 0.86 0.45 1.01

Dividend

Metric CANF SKYE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CANF SKYE Biotechnology median
Market cap 4.86m 4.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack